The CDC20 (50.25 ± 1.74 vs 23.67 ± 3.43, p < 0.01) and CCNA2 (46.65 ± 1.44 vs 24.67 ± 2.43, p < 0.01) shows significantly higher expression in endometrial cancer than cancer adjacent tissue. Here, CDC20 is linked to endometrial cancer.